Canada markets closed

Aridis Pharmaceuticals, Inc. (ARDS)

OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
19,602
0
0
0
0
Operating Expenses
Research Development
17,381
25,923
36,936
16,956
24,083
Selling General and Administrative
5,861
7,161
7,310
6,445
6,026
Total Operating Expenses
20,485
29,993
42,711
22,401
29,087
Operating Income or Loss
-883
-29,993
-42,711
-22,401
-29,087
Total Other Income/Expenses Net
-436
-257
763
-9
-951
Income Before Tax
-1,142
-30,371
-42,193
-22,333
-29,681
Income from Continuing Operations
-1,142
-30,371
-42,193
-22,333
-29,681
Net Income
-1,142
-30,371
-42,193
-22,333
-29,681
Net Income available to common shareholders
-1,142
-30,371
-46,320
-22,333
-29,681
Basic EPS
-0.12
-1.62
-3.85
-2.44
-3.51
Diluted EPS
-0.16
-1.62
-3.85
-2.44
-3.51
Basic Average Shares
32,173
18,777
12,292
9,169
8,458
Diluted Average Shares
40,885
18,777
12,292
9,169
8,458